Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVW-1001 in Dry Eye Disease
NCT06400459Phase 2Completed
- Sponsor
- IVIEW Therapeutics Inc.
- Start
- Jun 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of IVW-1001 in dry eye disease (DED), sponsored by IVIEW Therapeutics Inc.. Started Jun 2024; status: completed.
02
Drugs
IVW-1001
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06400459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06400459.